The emergency management of headaches

Neurologist

Volumn 9, Issue 2, 2003, Pages 93-98

  Green, Mark W ^a,b  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b NewYork Presbyterian Columbia University Irving Medical Center   (United States)

Author keywords

Emergency; Headache; Management

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; BUTALBITAL; BUTORPHANOL; CORTICOSTEROID; DICLOFENAC; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; ERGOT DERIVATIVE; ERGOTAMINE TARTRATE; INDOMETACIN; KETOROLAC; LIDOCAINE; MAGNESIUM SULFATE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PLACEBO; PROCHLORPERAZINE; PROPOFOL; SEROTONIN 3 ANTAGONIST; SEROTONIN AGONIST; SUMATRIPTAN; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VASOCONSTRICTOR AGENT; ZOLMITRIPTAN;

AKATHISIA; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLUSTER HEADACHE; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; DYSTONIA; EMERGENCY TREATMENT; EXTRAPYRAMIDAL SYMPTOM; FLUID THERAPY; HEADACHE; HUMAN; INTRAVENOUS ADMINISTRATION; MIGRAINE; NAUSEA; OXYGEN BREATHING; OXYGEN THERAPY; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SYMPTOM; TENSION HEADACHE;

CLUSTER HEADACHE; EMERGENCY MEDICAL SERVICES; HEADACHE; HUMANS; MIGRAINE DISORDERS; OXYGEN INHALATION THERAPY; SEROTONIN AGONISTS; TENSION-TYPE HEADACHE;

EID: 0037344859     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000051443.03160.72     Document Type: Review

References (27)

1. Clouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed care setting. Ann Pharmacother. 1994;28: 659-664.
2. Del Rio MS, Silberstein S. How to pick optimal acute treatment for migraine headache. Curr Pain Headache Reports. 2001;5:170-178.
3. Cady RK, Sheftell F, Lipton PB, et al. Effect of early intervention with sumatriptan on migraine pain: retrospective analysis of data from three clinical trials. Clin Ther. 2000;22:1035-1048.
4. Seim MB, March JA, Dunn KA. Intravenous ketorolac vs. intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 1998;5:573-576.
5. Edson K et al. Diclofenac-K/Sumatriptan Migraine Study Group. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. Cephalalgia. 1999;19:232-240.
6. Jones EB, Gonzales ER, Boggs JG, et al. Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Ann Emerg Med. 1996;24:191-195.
7. Jones J, Pack S, Chun E. Intramuscular prochlorperazine vs metoclopramide as a single-agent for the treatment of acute migraine headache. Am J Emerg Med. 1996;14:262-264.
8. Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine vs metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26: 541-546.
9. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26:168-171.
10. Berde B, Stuermer E. Introduction to the pharmacology of ergot alkaloids and related compounds as a basis of their therapeutic application. In: Berde B, Schild HO, eds. Ergot Alkaloids and Related Compounds Berlin: Springer-Verlag, 1978;1-28.
11. Winner P, Ricalde O, Leforce B, et al. A double-blind study of subcutaneous dihydroergotamine vs. subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 1996;53:590-592.
12. Norton J. Use of intravenous valproate sodium in status migraine. Headache. 2000;40:755-757.
13. Matthew NT, Kailasam J, Meadors L, et al. Intravenous valproate sodium (Depacon) aborts migraine rapidly: a preliminary report. Headache. 2000;40:720-723.
14. Maisels M, Geiger A. Intranasal lidocaine for migraine: a randomized trial and open-label follow-up. Headache. 1999;39:543-551.
15. Blanda M, Rench T, Gerson LW, et al. Intranasal lidocaine for the treatment of migraine headache: a randomized, controlled trial. Acad Emerg Med. 2001;8:337-342.
16. Gallagher M. Emergency treatment of intractable migraine. Headache. 1986;26:74-75.
17. Gray PN, McCrory DC, Eberlein K, et al. Drug treatments for acute migraine therapy. Agency for Health Care Policy and Research. 1999; 290-94-2025. National Technical Information Service Accession No. 127854.
18. Demirkaya S, Vural O, Dora B, et al. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache. 2001;41:171-177.
19. Krasc, JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache. 2000;40: 224-230.
20. Rasmussen B, Jensen R, Schroll M, et al. Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol. 1991;44: 1147-1157.
21. Diener HC, Tfelt-Hansen P. Headache associated with chronic use of substance. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press, 1993;721-727.
22. Ekbom K. A clinical comparison of cluster headache and migraine. Acta Neurol Scand. 1970;46:225-237.
23. Kudrow L. Physical and personality characteristics in cluster headache. Headache. 1974;13:197-201.
24. Ekbom K. Treatment of acute cluster headache with sumatriptan. N Engl J Med. 1991;325:322-326.
25. Bahra A, Gawel JE, Hardebo JE, et al. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology. 2000;54:1832-1839.
26. Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache. 1981;21:1-4.
27. Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen vs air inhalation. Headache. 1985;42:362-363.